Bienes Cambio Fecha
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Biogen USD 32.05B 32.5M 2026-09
Brainstorm Cell Therapeutics USD 788K 33K 2026-06
Cipla INR 434.34B 9.38B 2026-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 138.36M 7.5M 2026-06
CSL USD 37.9B 1.5B 2025-12
Cytokinetics USD 1.82B 99.77M 2026-09
Gilead Sciences USD 51.41B 2.05B 2026-09
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
Mesoblast USD 773.08M 9.23M 2026-06